Fresenius Medical Care Central Delaware is a medicare approved dialysis facility center in Dover, Delaware and it has 25 dialysis stations. It is located in Kent county at Blue Hen Corporate Center, Dover, DE, 19901. You can reach out to the office of Fresenius Medical Care Central Delaware at (302) 678-5718. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care Central Delaware has the following ownership type - Profit. It was first certified by medicare in December, 1978. The medicare id for this facility is 082502 and it accepts patients under medicare ESRD program.
Name | Fresenius Medical Care Central Delaware |
---|---|
Location | Blue Hen Corporate Center, Dover, Delaware |
No. of Dialysis Stations | 25 |
Medicare ID | 082502 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | Yes |
Blue Hen Corporate Center, Dover, Delaware, 19901 | |
(302) 678-5718 | |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
NPI Number | 1568753341 |
Organization Name | Fresenius Medical Care Central Delaware |
Doing Business As | Fresenius Medical Care Southern Delaware, Llc |
Address | 655 S Bay Rd Dover, Delaware, 19901 |
Phone Number | (302) 678-5718 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
NPI Number | 1730284514 |
Organization Name | Rcc Central Delaware |
Doing Business As | National Medical Care, Inc. |
Address | Blue Hen Corporate Center Dover, Delaware, 19904 |
Phone Number | (302) 678-5718 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that nephrologists always communicated and cared for them. | 37% | 67% |
Patients who reported that nephrologists usually communicated and cared for them. | 27% | 15% |
Patients who reported that nephrologists sometimes or never communicated and cared for them. | 36% | 18% |
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 21% | 60% |
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 37% | 26% |
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 42% | 14% |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 57% | 62% |
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 27% | 20% |
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 16% | 18% |
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 53% | 62% |
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 39% | 26% |
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 8% | 12% |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 76% | 80% |
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 24% | 20% |
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 61% | 68% |
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 20% |
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 9% | 12% |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
Dialysis patients with Hemoglobin data | 80 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 19 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 115 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 1077 |
Percentage of adult patients getting regular hemodialysis at the center | 98 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care Central Delaware with elevated calcium levels.
Patients with hypercalcemia | 117 |
Hypercalcemia patient months | 1097 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
Patients with Serumphosphor | 124 |
Patients with Serumphosphor less than 3.5 mg/dL | 16 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
Patients with Serumphosphor greater than 7 mg/dL | 8 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 119 |
Patient months included in arterial venous fistula and catheter summaries | 964 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 59 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 107 |
Hospitalization Rate in facility | 205.2 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 326.1 |
Hospitalization Rate: Lower Confidence Limit | 138.4 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at Fresenius Medical Care Central Delaware were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 25.7 (As Expected) |
Readmission Rate: Upper Confidence Limit | 36.2 |
Readmission Rate: Lower Confidence Limit | 17 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Medical Care Central Delaware get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | .75 (As Expected) |
SIR: Upper Confidence Limit | 1.56 |
SIR: Lower Confidence Limit | .3 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care Central Delaware's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 80 |
Transfusion Rate in facility | 30 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 74.7 |
Transfusion Rate: Lower Confidence Limit | 13.5 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at Fresenius Medical Care Central Delaware lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 491 |
Mortality Rate in facility | 19.2 (As Expected) |
Mortality Rate: Upper Confidence Limit | 24.3 |
Mortality Rate: Lower Confidence Limit | 14.9 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago
Fresenius Medical Care Central Delaware Location: Blue Hen Corporate Center, Dover, Delaware, 19901 Phone: (302) 678-5718 |
Fresenius Medical Care Greentree Location: 97 Commerce Way, Suite 104, Dover, Delaware, 19904 Phone: (302) 674-1919 |
Fresenius Medical Care Southern Delaware, Llc Location: 1198 South Governors Avenue, Dover, Delaware, 19904 Phone: (302) 736-1340 |
News Archive
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Even small amounts of breastmilk strongly influences the accumulation of viral populations in the infant gut and provides a protective effect against potentially pathogenic viruses, according to researchers who examined hundreds of babies in a study from the Perelman School of Medicine at the University of Pennsylvania.
A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans.
› Verified 9 days ago